Wendy Carruthers
Known title: DirectorCIK: 0001563565
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Boston Scientific (BSX) Faces Catheter Recall Amid Valuation Debate. Boston Scientific announced a recall of 262,686 catheters because of a life‑threatening tip failure risk. The recall adds pressure as analysts note the company needs clear evidence of its turnaround to justify a better valuation. Truist Securities kept its rating but cut its price target to $51, reflecting a more cautious view. The stock has still moved higher than the broader market, indicating mixed investor reactions.
Transaction History
| NVST | ▲ Buy | Grant | 9,330 | $0 | 5/19/2026 | View on chart |
| NVST | ▲ Buy | Grant | 10,450 | $0 | 6/10/2025 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,066 | $53K | 12/2/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,197 | $29K | 12/2/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 6,983 | $634K | 12/2/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,066 | $53K | 11/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,197 | $29K | 11/1/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 6,983 | $589K | 11/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,066 | $53K | 10/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,197 | $29K | 10/1/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 6,983 | $586K | 10/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,066 | $53K | 9/3/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,197 | $29K | 9/3/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 6,983 | $571K | 9/3/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,066 | $53K | 8/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,197 | $29K | 8/1/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 6,983 | $518K | 8/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,197 | $29K | 7/1/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 6,983 | $540K | 7/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,066 | $53K | 7/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,066 | $53K | 6/3/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,197 | $29K | 6/3/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 6,983 | $526K | 6/3/2024 | View on chart |
| NVST | ▲ Buy | Grant | 10,085 | $0 | 5/21/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,066 | $53K | 5/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,197 | $29K | 5/1/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 6,983 | $499K | 5/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,066 | $53K | 4/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,197 | $29K | 4/1/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 6,983 | $478K | 4/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,066 | $53K | 3/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,197 | $29K | 3/1/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 6,983 | $463K | 3/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,066 | $53K | 2/23/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,197 | $29K | 2/23/2024 | View on chart |
| BSX | ▼ Sell | Open Market | 6,983 | $467K | 2/23/2024 | View on chart |
| BSX | ▼ Sell | Gift | 3,050 | $0 | 2/20/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,853 | $0 | 2/18/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 822 | $54K | 2/18/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 998 | $66K | 2/17/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,250 | $0 | 2/17/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,051 | $0 | 2/16/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 910 | $60K | 2/16/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,115 | $0 | 2/14/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 939 | $62K | 2/14/2024 | View on chart |
| BSX | ▲ Buy | Grant | 18,000 | $0 | 2/6/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 7,983 | $0 | 2/6/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 11,772 | $0 | 1/1/2024 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 5,380 | $311K | 1/1/2024 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,450 | $56K | 12/15/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,959 | $39K | 12/15/2023 | View on chart |
| BSX | ▼ Sell | Open Market | 11,672 | $649K | 12/15/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,448 | $56K | 11/15/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,960 | $39K | 11/15/2023 | View on chart |
| BSX | ▼ Sell | Open Market | 11,671 | $632K | 11/15/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,448 | $56K | 10/16/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,960 | $39K | 10/16/2023 | View on chart |
| BSX | ▼ Sell | Open Market | 11,671 | $581K | 10/16/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,448 | $56K | 9/15/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,960 | $39K | 9/15/2023 | View on chart |
| BSX | ▼ Sell | Open Market | 11,671 | $630K | 9/15/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,448 | $56K | 8/15/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,960 | $39K | 8/15/2023 | View on chart |
| BSX | ▼ Sell | Open Market | 11,671 | $599K | 8/15/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,448 | $56K | 7/17/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,960 | $39K | 7/17/2023 | View on chart |
| BSX | ▼ Sell | Open Market | 11,671 | $617K | 7/17/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,448 | $56K | 6/15/2023 | View on chart |
| BSX | ▼ Sell | Open Market | 11,671 | $621K | 6/15/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,960 | $39K | 6/15/2023 | View on chart |
| NVST | ▲ Buy | Grant | 5,425 | $0 | 5/23/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,448 | $56K | 5/15/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,960 | $39K | 5/15/2023 | View on chart |
| BSX | ▼ Sell | Open Market | 11,671 | $624K | 5/15/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,448 | $56K | 4/17/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,960 | $39K | 4/17/2023 | View on chart |
| BSX | ▼ Sell | Open Market | 11,671 | $606K | 4/17/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 3,448 | $56K | 3/15/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,960 | $39K | 3/15/2023 | View on chart |
| BSX | ▼ Sell | Open Market | 11,671 | $556K | 3/15/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,558 | $0 | 2/21/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 691 | $32K | 2/21/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,853 | $0 | 2/18/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 822 | $38K | 2/18/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,250 | $0 | 2/17/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 998 | $46K | 2/17/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,050 | $0 | 2/16/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 910 | $42K | 2/16/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,661 | $0 | 2/15/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 737 | $35K | 2/15/2023 | View on chart |
| BSX | ▼ Sell | Gift | 2,195 | $0 | 2/10/2023 | View on chart |
| BSX | ▲ Buy | Option Exercise | 6,567 | $0 | 1/1/2023 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 3,100 | $143K | 1/1/2023 | View on chart |
| BSX | ▼ Sell | Open Market | 7,500 | $350K | 12/15/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 1,678 | $71K | 11/15/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 13,322 | $540K | 10/17/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 7,500 | $317K | 9/15/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 7,500 | $315K | 8/15/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 7,500 | $285K | 7/18/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 7,500 | $285K | 6/24/2022 | View on chart |
| NVST | ▲ Buy | Grant | 4,435 | $0 | 5/24/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 7,500 | $296K | 5/16/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 7,500 | $334K | 4/14/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 7,500 | $318K | 3/15/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,630 | $0 | 2/28/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 479 | $21K | 2/28/2022 | View on chart |
| BSX | ▼ Sell | Gift | 2,300 | $0 | 2/23/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,558 | $0 | 2/21/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 458 | $19K | 2/21/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,853 | $0 | 2/18/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 544 | $23K | 2/18/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 2,250 | $0 | 2/17/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 661 | $28K | 2/17/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 1,661 | $0 | 2/15/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 488 | $21K | 2/15/2022 | View on chart |
| BSX | ▲ Buy | Option Exercise | 5,614 | $0 | 1/1/2022 | View on chart |
| BSX | ▼ Sell | Tax Withholding | 1,832 | $78K | 1/1/2022 | View on chart |
| BSX | ▼ Sell | Open Market | 3,321 | $136K | 12/15/2021 | View on chart |
| BSX | ▼ Sell | Open Market | 3,321 | $140K | 11/15/2021 | View on chart |
| BSX | ▼ Sell | Open Market | 3,322 | $145K | 10/15/2021 | View on chart |
| BSX | ▼ Sell | Open Market | 3,321 | $149K | 9/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Piper Sandler cuts Envista price target to $26, maintains Neutral
Piper Sandler recently lowered its price target for Envista Holdings to $26 while keeping a Neutral stance. This move aligns with the stock's current trading level near its 52-week low of $18.77. The company has also scheduled its third-quarter 2026 earnings call, which will provide updated financial insights.
Piper Sandler cuts Envista price target to $26, maintains Neutral. Piper Sandler recently lowered its price target for Envista Holdings to $26 while keeping a Neutral stance. This move aligns with the stock's current trading level near its 52-week low of $18.77. The company has also scheduled its third-quarter 2026 earnings call, which will provide updated financial insights.